Zostavax historical
Selected indexed studies
- Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications. (EClinicalMedicine, 2025) [PMID:40630610]
- Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia. (J Alzheimers Dis, 2024) [PMID:38393913]
- Global Status of Adult Immunization Post COVID-19 Pandemic. (Vaccines (Basel), 2025) [PMID:40333313]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications. (2025) pubmed
- Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia. (2024) pubmed
- Global Status of Adult Immunization Post COVID-19 Pandemic. (2025) pubmed
- Aetiologies, neuroradiological features, and risk factors for mortality and long-term neurosequelae of febrile coma in Malawian children: a prospective cohort study. (2025) pubmed
- The epidemiology of varicella-zoster virus infections. (1996) pubmed
- Application of Multivariate Data Analysis on Historical Recombinant Adenovirus Zoster Vaccine Production Data for Upstream Process Improvements. (2024) pubmed
- Understanding the role of exogenous boosting in modeling varicella vaccination. (2018) pubmed
- Update in Herpes Zoster Prevention and the Role of Dermatologists. (2019) pubmed
- Herpes zoster-associated mortality in Europe: a systematic review. (2015) pubmed
- Real-World Effectiveness of Recombinant Zoster Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients. (2026) pubmed